Activated platelets and platelet-derived extracellular vesicles (EVs) have emerged as central
players in thromboembolic complications associated with severe coronavirus disease 2019 …

Thrombosis plays an important role in induction of Coronavirus disease 19 (COVID-19)
complications including heart attack and stroke. Reliable biomarkers are needed to predict …

Although the precise pathogenesis of coronavirus disease 2019 (COVID-19) currently
remains unknown, its complex nature is gradually being revealed. COVID-19 is a disease …

The authors hypothesized that the cytokine storm described in COVID-19 patients may lead
to consistent cell-based tissue factor (TF)-mediated activation of coagulation, procoagulant …

Platelets and platelet extracellular vesicles (pEV) are at the crossroads of coagulation and
immunity. Extracellular vesicles are messengers that not only transmit signals between cells …

Objective: Pulmonary thrombosis is observed in severe acute respiratory syndrome
coronavirus 2 pneumonia. Aim was to investigate whether subpopulations of platelets were …

Introduction Increased levels of extracellular vesicles (EVs) are associated with haemostatic
disturbances in various clinical settings. However, their role in COVID‐19 patients is still not …

Coronavirus disease 2019 (COVID-19) induces a hypercoagulatory state that frequently
leads to thromboembolic complications. Whereas anticoagulation is associated with …

COVID-19 infection is associated with a broad spectrum of presentations, but alveolar
capillary microthrombi have been described as a common finding in COVID-19 patients …

As more is learned about the pathophysiological mechanisms of COVID-19, systemic
thrombosis has been recognized as being associated with more severe clinical …